Nathan Bahary, MD, PhD
UPMC Hillman Cancer Center
1
1
1
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (1)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Midhun Malla, MD, MS
University of Alabama at Birmingham
Shared therapeutic areas:
Olivia Aranha, M.D., Ph.D.
Washington University School of Medicine
Shared therapeutic areas:
Vaibhav Sahai, MBBS, MS
University of Michigan
Shared therapeutic areas:
Rajat Thawani
OHSU Knight Cancer Institute
Shared therapeutic areas:
Sameek Roychowdhury, MD, PhD
Ohio State University Comprehensive Cancer Center
Shared therapeutic areas:
Vikas Ostwal, DM
Tata Memorial Hospital, Parel, Mumbai, Maharashtra, India 400012
Shared therapeutic areas:
Devalingam Mahalingam, MD, PhD
Northwestern University
Shared therapeutic areas:
Tanios S Bekaii-Saab
Academic and Community Cancer Research United
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
A Phase 2 Trial of Regorafenib as A Single Agent in Advanced and Metastatic Biliary Tract Carcinoma/Cholangiocarcinoma Patients Who Have Failed First-line Chemotherapy
All 1 trials loaded